S-METHYLATION IN MOTORNEURON DISEASE AND PARKINSON'S DISEASE
- 12 August 1989
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 334 (8659), 356-357
- https://doi.org/10.1016/s0140-6736(89)90538-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Xenobiotic metabolism in Parkinson's diseaseNeurology, 1989
- XENOBIOTIC METABOLISM IN MOTORNEURON DISEASEThe Lancet, 1988
- MOTORNEURONE DISEASE AS MANIFESTATION OF PESTICIDE TOXICITYThe Lancet, 1987
- Long term exposure to hydrogen sulphide producing subacute encephalopathy in a child.BMJ, 1987
- Thiol methylation pharmacogenetics: Heritability of human erythrocyte thiol methyltransferase activityClinical Pharmacology & Therapeutics, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfideBiochemical Pharmacology, 1980
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Human erythrocyte thiol methyltransferase: Radiochemical microassay and biochemical propertiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- The Metabolism ofS-Carboxymethylcysteine in Rodents, Marmosets and HumansXenobiotica, 1978